SOURCE: Model N, Inc.

June 19, 2008 06:00 ET

Model N Introduces Next Generation of High-Performance Revenue Management for Life Science Organizations

Release 5.3 Includes First-of-Its-Kind Revenue Planning and Analytics That Align Operational and Decision Support Capabilities; Also Incorporates Advanced Channel Management

PHILADELPHIA, PA--(Marketwire - June 19, 2008) - Model N, Inc., the leader in Revenue Management solutions, today announced the launch of Release 5.3 of its best-of-breed Pharmaceutical and Medical Technology Revenue Management Suites at CBI's 4th Annual Commercial Contracts and Chargeback Management for Manufacturers and Wholesalers conference. Designed to easily integrate with SAP and other leading ERP systems, the new release reflects Model N's continued momentum in the Life Science marketplace and dedication to addressing the needs of Life Science organizations in both their commercial and government lines of business.

Release 5.3 delivers a breakthrough in leveraging the rich operational information available in the industry's only integrated, production-proven Revenue Management Suite by introducing unique capabilities for planning and modeling the implications of pricing and contracting decisions on revenue and reimbursement liabilities. Addressing a top concern of Life Science executive management, the new Revenue Planning and Intelligence application enables unprecedented visibility into financial performance and the downstream implications of both internal and external business changes. The release also extends the suite's application footprint to address emerging channel management trends such as Fee-for-Service.

"Technology has often taken two paths to addressing critical business issues: transactional systems that solve operational challenges, or decision support systems that analyze the results of operational processes," said Sujay Jadhav, General Manager, Model N Life Sciences. "With Release 5.3, we have combined our industry-leading transactional functionality with robust decision support capabilities to create a unique application suite that addresses both key business needs. With more than 25 companies deploying the Model N platform in the last two years, it's clear that the industry is embracing and benefiting from our breakthrough solutions."

New Solutions


Many leading Life Science wholesalers and distributors have begun instituting fee-for-service (FFS) contracts with manufacturers. With Model N Fee-for-Service, pharmaceutical and medical technology companies employing indirect sales channels now have a powerful tool to model and manage the accumulation, calculation, and payment of fees to their wholesalers and distributers.

The solution automates FFS processes by creating and managing FFS programs per contract, calculating and managing fees as they accrue, setting up payment packages, accurately calculating payments based on incoming sales data, and then publishing this data to Model N Government Pricing on a transaction-by-transaction level.

Key benefits of Model N Fee-for-Service include:

--  Improved payment calculation accuracy, shortened processing time
--  Reduced overpayments, enhanced channel relations
--  Direct integration with Model N Government Pricing for pharmaceutical
    manufacturers, full auditability

Revenue Planning and Intelligence

Model N Revenue Planning and Intelligence provides CFOs, finance executives, and government pricing and compliance managers with unparalleled revenue planning, risk assessment, and business intelligence capabilities. Designed to meet the unique business requirements of the pharmaceutical industry, the solution helps manufacturers enhance revenue planning and mitigate regulatory risk by:

--  Delivering real-time, strategic business intelligence to Government
    Pricing and Medicaid programs
--  Providing finance executives and managers with the  tools to make
    informed revenue strategy decisions
--  Empowering finance and sales executives to accurately forecast and
    model the liability impact of regulatory and commercial scenarios to
    maximize profit

Additional Capabilities in 5.3

In addition to Fee-for-Service and Revenue Planning and Intelligence, 5.3 introduces numerous customer-requested solution enhancements and platform updates, including:

--  Automatic Creation of Medicaid State Supplemental Claims: creates a
    link between federal and state supplemental programs that improves
    processing efficiency
--  Government Pricing Dashboard: provides financial and sales management
    an overview of government pricing reporting status through targeted
    embedded report pages with quick drill-downs
--  Custom Sales Types: provides a flexible means of importing and
    utilizing sales information from non-standard sources
--  Advanced Composite Rebate Programs: streamlines the creation of
    complex rebate programs and provides an "at-a-glance" overview of proposed
    deals that replicates the layout of typical paper-based contracts
--  Technology Platform Updates: enhanced configuration management,
    performance monitoring application, support for 64-bit operating systems,
    Cognos 8.3, Oracle 10g; and more

SAP Integration

Model N seamlessly integrates with SAP and other ERP systems to complete the order-to-cash life cycle. The Revenue Management suite is SAP-certified and powered by SAP NetWeaver, and the Model N professional services organization has a proven record of implementing scalable, vertically tailored solutions that utilize and complement SAP ERP systems to enable the exchange of critical data such as real-time pricing information and nightly batch updating.

More Information

To learn more, attend our Web Seminar on July 2 at 10 a.m. PDT. The seminar will explore in more detail the important new features and functionality available in Release 5.3.

About Model N

Model N is the leader in Revenue Management solutions, offering an integrated suite of applications for pricing, contracts, compliance, rebates, fees, and chargebacks optimized for the industry practices of life sciences companies, with the only integrated government pricing and Medicaid claims processing capabilities in the industry. Enabling the creation of a seamless, end-to-end process from pricing through settlements payment, Model N's uniquely integrated approach eliminates revenue leakage and delivers the visibility and controls needed to avoid the risks of non-compliance to government pricing and Sarbanes-Oxley regulations. Customers include Astellas Pharma US, Inc.; Axcan Pharma; Boston Scientific; Bristol-Myers Squibb; Gilead Sciences; MedImmune, Inc.; Medtronic, Inc.; Novo Nordisk, Inc.; Ortho-Clinical Diagnostics, a Johnson & Johnson company; and Pfizer, Inc. Model N is located in Redwood Shores, California. For additional information, visit

Contact Information